MABVAX THERAPEUTICS HLDGS IN

CUSIP: 55414P702 Class: COM PAR

Cambridge Investment Research Advisors, Inc.'s Holding History (CIK: 0001419186)

Note: Option positions (PUT/CALL) are excluded.

Q2 2019
Shares 582,855 Value ($000) $29 Avg Close — Range —
Q2 2018
Shares 1,030,310 Value ($000) $876 Avg Close — Range —
Q1 2018
Shares 980,343 Value ($000) $1,480 Avg Close — Range —